πŸ‡ΊπŸ‡Έ FDA
Patent

US 8440813

Antiviral nucleoside analogs

granted A61PA61P31/00A61P31/12

Quick answer

US patent 8440813 (Antiviral nucleoside analogs) held by BioCryst Pharmaceuticals, Inc. expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P31/00, A61P31/12, A61P31/14, A61P35/00